BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Duchesne L, Hejblum G, Toure Kane NC, Njouom R, Toni TD, Moh R, Sylla B, Rouveau N, Attia A, Lacombe K. Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in people who use injecting drugs in Senegal. Int J Drug Policy 2020;75:102613. [PMID: 31786434 DOI: 10.1016/j.drugpo.2019.102613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Fraser H, Stone J, Wisse E, Sambu V, Mfisi P, Duran IJ, Soriano MA, Walker JG, Makere N, Luhmann N, Kafura W, Nouvellet M, Ragi A, Mundia B, Vickerman P. Modelling the impact of HIV and HCV prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania. J Int AIDS Soc 2021;24:e25817. [PMID: 34661964 DOI: 10.1002/jia2.25817] [Reference Citation Analysis]
2 Bajis S, Applegate TL, Grebely J, Matthews GV, Dore GJ. Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic. J Infect Dis 2020;222:S758-72. [PMID: 33245354 DOI: 10.1093/infdis/jiaa366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ryan P, Valencia J, Cuevas G, Troya J, Ramon C, Rodríguez A, Torres-Macho J, Muñoz-Gómez MJ, Canorea I, Vázquez-Morón S, Resino S. HCV screening based on dried blood samples and linkage to care in people who use drugs: A prospective study. Int J Drug Policy 2021;92:103134. [PMID: 33517130 DOI: 10.1016/j.drugpo.2021.103134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Heidt B, Siqueira WF, Eersels K, Diliën H, van Grinsven B, Fujiwara RT, Cleij TJ. Point of Care Diagnostics in Resource-Limited Settings: A Review of the Present and Future of PoC in Its Most Needed Environment. Biosensors (Basel) 2020;10:E133. [PMID: 32987809 DOI: 10.3390/bios10100133] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
5 Duchesne L, Hejblum G, Njouom R, Touré Kane C, Toni TD, Moh R, Sylla B, Rouveau N, Attia A, Lacombe K. Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in Central and Western Africa. PLoS One 2020;15:e0238035. [PMID: 32833976 DOI: 10.1371/journal.pone.0238035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]